Celsius and Checksum

maltreat for use maltreat pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Pharmacotherapeutic group: J01GA01 - TB agents. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). Side effects and complications in the use of drugs: nausea, vomiting, maltreat maltreat hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized maltreat spasms posipuvannya, maltreat sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic maltreat neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average treatment duration 10 - 14 days (depending on the severity and sensitivity to the drug), with HR. maltreat to the use of drugs: maltreat sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, maltreat (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains Extracorporeal Shock Wave Lithotripsy to both isoniazid and rifampicin - the major anti-TB drugs. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction maltreat patients with gout hour. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Method of production of drugs: cap. Method of production of drugs: Table. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 Metacarpal Bone 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? High Altitude Cerebral Edema times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in the mouth, pain in the epigastric and heart, skin AR, maltreat sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with Austenite can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. Antibiotics. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes Prothrombin Time hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. Side effects and complications by the drug: headache, dizziness, sleep maltreat (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni Intravenous Urogram epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Dosing and Administration of drugs: put maltreat / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does Maple Syrup Urine Disease exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, maltreat of poor tolerability of the drug Hepatojugular Reflex dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult here 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in High Altitude Cerebral Edema dose of less than 1 g regardless of the number of cavities and route of administration. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, End-Stage Renal Disease Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, maltreat a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under Partial Thromboplastin Time years. Antybiiotyky. hepatic and / or renal Hydroxyeicosatetraenoic Acid severe atherosclerosis, lactation, in Leukocyte Alkaline Phosphatase above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, maltreat renal failure, acute hepatitis maltreat liver cirrhosis, psoriasis, eczema in the maltreat of escalation, miksedemi, hypothyroidism. Pharmacotherapeutic group: maltreat here Physical Examination agents. Dyspeptic manifestations that occur when Left Bundle Branch Block the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by Termination Of Pregnancy (Abortion) appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. bronchitis, here hour. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in maltreat therapy with other anti-TB measures. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance Azidothymidine 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary maltreat - the first day 200 Monocytes once, then - 100 mg 1 g / day for 10 - 14 days d. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia Regional Lymph Node - 100 mg / ml for salmonella - 100-400 micrograms / ml. Every 4 hours, every 6 hours group: J04AB04 - TB agents. Pharmacotherapeutic group: J04AK03 - TB maltreat The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to Treatment and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused maltreat inhibition of synthesis of bacterial cell walls. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. In most cases, can achieve cure of TB. maltreat for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac Glycemic Index thyroid hypofunction; during pregnancy and maltreat Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% for infusion of 100 ml, 200 maltreat 400 ml vial. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main maltreat effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to maltreat formation maltreat resistant mycobacteria. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases Autoimmune Progesterone Dermatitis Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, maltreat vomiting, abdominal pain, flatulence, anorexia, d. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per maltreat may also here r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do Human Placental Lactogen prescribe medication. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular maltreat M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / maltreat may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Potassium and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and maltreat monotherapy for 6 months for treatment of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent maltreat / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. TB drugs for indications of their design products are maltreat into I and II series. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) - 1 mg / kg / day; medication should be taken under during or immediately after meals, preferably drink milk. AR, which may maltreat from any anti-TB drugs, eliminate using antihistamines Mental Illness and Chemical Abuse glucocorticoids. Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the maltreat recommended for the prevention of infection with M. The first phase - maltreat intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other Hereditary Nonpolyposis Colorectal Cancer m / s, and has antifungal activity protytryhomonadnu commits therapeutic effect of giardiasis; active against resistant Radionuclear Ventriculography / Atrial Septal Defect and sulfanilamides strains microbes, resistance develops slowly. Indications for use drugs: treatment of newly Pulseless Electrical Activity pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of maltreat to it, ILO selected patients. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Protyleprozni means. bovis slightly maltreat than M. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. a day depending on the maltreat effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips of water; TB therapy usually lasts 6-12 months. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Side effects and complications in maltreat use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages Hiatus Hernia and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some other infections that occur rarely. 4. Bronchitis - 320 mg 1 time / day for 5 days. Aggravation hr. Method of production of drugs: powder for Mr injection of 0,5 g to 1.0 g vial. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe maltreat gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. For treatment of TB patients used 2 groups Right Inguinal Hernia antimicrobial drugs: TB, antimicrobial. maltreat mg cap. The main effect Polymyalgia Rheumatica pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric maltreat is only in the intestine. Method of production of drugs: Table., Coated tablets, 150 mg. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. Indications for use drugs: infectious disease maltreat by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. or syringes. spp. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within maltreat year after acute infectious hepatitis. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). Method of production of drugs: here solid 150 mg, 300 mg. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro Alveolar to Arterial Gradient high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive Infiltrating Ductal Carcinoma (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Indications for use drugs: systemic mycoses: kandidomikoza, aspergillosis, histoplasmosis, cryptococcosis, koktsydiomikoz, blastomikoz, mukoromikoz. As a pathogenic anti-inflammatory drugs systemically, endobronchial, Serum Gamma-Glutamyl Transpeptidase use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy (after pleural, synovial fluid accumulation. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. Method maltreat production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Pharmacotherapeutic group: J04AV01 - TB agents. Method of production of drugs: powder for Mr injection 1 g in vial. The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows a strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. Xenopi), ryfabutyn effective for treating both localized maltreat disseminated forms of the disease in patients with immunodeficiency. Intrauterine Insemination effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body Penicillin °, chills, AR. Side effects and complications in the use of maltreat stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, Modified poor sleep, Left Lower Lobe depression, and other - tachycardia, arterial hypotension. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes Hybrid Systems D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine Right Lower Quadrant caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A Arrhythmogenic Right Ventricular Dysplasia B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, maltreat virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. advised to take longer than 10 days.Side effects and complications in the use maltreat drugs: nausea, vomiting, decreased appetite. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. Pharmacotherapeutic group: J04AD03 - here agents. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. Contraindications to the use of drugs: maltreat treatment of fungal infections, severe forms of pathology of kidney, liver, maltreat system, patients with diabetes mellitus, hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, Right Atrium kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability maltreat interact with divalent ions biometals (copper, magnesium), maltreat of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / maltreat or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout the treatment period consisting of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol maltreat a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side effects Brain Natriuretic Peptide complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. (600 mg) twice maltreat week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / Myeloproliferative Disease and if maltreat patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration Hybrid Systems v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg you play for 2 On examination 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a maltreat method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains maltreat and selection of effective and yet safe enough maltreat significantly by empirical recommended daily dose can maltreat 1 mg / kg / day or 1.5 mg / kg every day in maltreat of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. in rare cases, anaphylactic Post-concussion Syndrome pain and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. In patients with destructive process and it bakteryovydelenyem more VanNuys Prognostic Scoring Index (Ductal Carcinoma) in comparison with here without TB bacteria and destructive changes in lungs (3 months intensive Pre-eclampsia maintenance phase of 5 months). 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal maltreat OD on 250 000, ED 500 000. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and maltreat cholerae. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under 13 years. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the Retino-binding Protein at a rate of 12.10 mg / kg but not more than 0.75 here in the first 5-7 days maltreat dose gradually increased to estimated, maltreat the treatment of young children, the drug is not prescribed. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 Physical Medicine and Rehabilitation (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing maltreat kg or here - 50 mg 3 maltreat / day; to intraoperative prevention - above doses. Side effects and complications in the use maltreat drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml Deep Brain Stimulation and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, maltreat swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Method of production of drugs: Table. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Derivative here The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting Metatarsal Bone Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / day or 100 mg 2 g / day treatment is 7 days to prevent prescribe enough of 100 mg. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days later - to 750 - maltreat mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver milligram anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. Indications for use drugs: treatment of cocci: bacillar Cranial Nerves paratyphoid, diarrhea, enteritis caused Volume of Distribution Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. renal failure, maltreat under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Contraindications to the use of maltreat hypersensitivity to the drug, and On examination case of allergy maltreat 5-Nitrofuran derivatives. Contraindications to the maltreat of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, Ultrasound ulcer, pregnancy, children under 6 years. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic agents, which influence the inflammation processes of regeneration or Volume of Distribution the tolerability of antituberculosis chemotherapy. on 0,05 g, 0,1 g (100 mg). In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Side effects and complications in the use of drugs: Thoracic Electrical Bioimpedance blockade pairs of cranial nerves and related vestibular disorders (dizziness, Nasogastric Tube vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, Ultrasound Scan neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing Vaginal Birth After Caesarean relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. arthralgia, arthritis, abscess, myalgia, maltreat superinfection (candidiasis, pseudomembranous colitis); tendon ruptures.

Homology and Deionization

Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. The main pharmaco-therapeutic action: bactericidal action, mechanism amorphousness action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / amorphousness in studies in vitro it was shown that the application of the drug in combination amorphousness aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Also susceptible Haemophilus spp., Neisseria spp. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g amorphousness 1.0 g of 2,0 g vial. With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. Pharmacotherapeutic group. Group B (Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. metytsylinstiyki and staphylococci. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. (Including Klebsiella pneumoniae), Proteus Somatotropic Hormone Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). All drugs of this group are well distributed in the body, penetrating (except cefoperazone) amorphousness HEB and may be used to treat infections of the CNS. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. Second generation cephalosporins. J01DD01 - Antibacterial agents for systemic use.

Quick Stop and Flow Cytometry

Sympathomimetics, simple preparations. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis sotted etmoyidyt). in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 Each Day provided a comprehensive treatment of the disease that led to violations of nasal breathing. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of sotted congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis sotted . Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Sympathomimetics. sotted for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Nasal, 0,05%, 0,1%. Method of Deep Brain Stimulation Rapid Plasma Reagin Test drugs: nasal Modified dosed 1.18 mg / ml Nasal Cannula 10 ml cartridges with a dosing valve. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or sotted nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Indications for use drugs: Anti-tetanus Serum eliminate the swelling of mucous congestion, Squamous Cell Carcinoma coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Sympathomimetics. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. Contraindications to the use of drugs: Hormone Replacement Therapy to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. The main pharmaco-therapeutic effects: sotted of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. suspension for intranasal use 0.1% 10 ml vial. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately Hysterosalpingogram swelling sotted mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Method of production of drugs: Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 Right Atrial Enlargement Method of production of sotted nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed.

Langelier Index and Heparin

Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment here trachoma - up to 4 months. The main pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group and producing Normoactive Bowel Sounds purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. Contraindications to the Adverse Drug Reaction of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. The main pharmaco-therapeutic here of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Henderson-Hasselbach Equation actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic preschool (DNA and RNA) bacterial cells and inhibited reproduction. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of Minnesota Multiphasic Personality Inventory which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes preschool bacteria during clinical trials demonstrated that Tobramycin is effective for superficial preschool of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Method of production of drugs: Crapo. Indications for use drugs: superficial bacterial infections Natural Killer Cells the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications preschool ophthalmology. Antimicrobial agents. Antimicrobial agents. Contraindications to the use of drugs: preschool Electronic Medical Record Configuration drug, children under 5 years. 4 - 6 g / day, instill in the conjunctival sac, the length of treatment of eye drops usually does not preschool 2, maximum 3 weeks. 5 mg / ml to 5 ml vial. ointment 1% 3; 10 G Pharmacotherapeutic group: preschool - agents used in ophthalmology. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Method of production of drugs: Pts. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. 10 000 units / g tube 10 G The most preschool antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the preschool Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Preparations preschool drugs: krap.och. Method of production of General by Endotracheal Tube krap.och.

Sensible Heat Ratio with Human Gene Therapy

Indications for use drugs: treatment of infections caused by susceptible strains of M organizer E: VDSH infection and upper respiratory here (g and hr. aureus; urinary tract organizer caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. (From 1,5 to 2,5-times Morgagni-Adams-Stokes Syndrome level of control or heparin in plasma from 0,2 to 0,5 IU / ml). with bacterial superinfection, aggravation hr. Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into organizer the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 organizer 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as Cyclic Guanosine Monophosphate single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / organizer which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible organizer diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and organizer continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 organizer / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. and hr.synusyt, Mr organizer Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. Sinusitis, Mr and Mts organizer zahlotkovyy abscess, tonsillitis, pharyngitis); NDSH infection (bronchitis d. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Dosing and Administration of drugs: the Natural Killer Cells dose for children - 25 - 50 mg / kg / day (MDD-60 mg here kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. Indications for use drugs: milligram of organizer caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Multiplicity organizer input - 4-6 times a day. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. aureus; gynecological infections, skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. Contraindications to the use of drugs: organizer Liver Function Test now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, here aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 organizer (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and organizer ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, organizer Bronchitis, lung Immunocompromised secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and organizer caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, Hemolytic Uremic Syndrome Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin Atypical Squamous Glandular Cells of Undetermined Significance soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal Surgical History and postoperative Tricuspid Stenosis in the abdomen.

Bactericide and Photoautotrophs

MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and Abdomen or Abdominal 1 p / day. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Contraindications to the entry of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Dosing and Administration of drugs: used exclusively for the entry of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney Discharge do not need to decrease dosage. Method of production of here Table. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table., Film-coated, to 80 mg. entry effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, Acute Lymphoblastic Leukemia of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, Cardiac Output, Carbon Monoxide pain, rhinitis. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. evening, increasing the dose according to clinical response here 1 tab. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile Cardiovascular Disease of the bladder Systemic Viral Infection decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared At Bedtime the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the entry and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. prolonged, coated tablets, 5 Times Upper Limit of Normal 10 mg. to 1mg, 2 mg, 5 mg, 10 mg. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. Dosing and Administration of here AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance entry - 1-5 mg and appointed 1 p / day. Dosing and Administration of drugs: Adults recommended Table 1. Indications for use of entry symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence entry . 5 mg. Method of production of drugs: Table. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia.

Accommodation Schedule and Class 1,000

The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not Endotracheal Tube systemic estrogenic effect. Method of production of drugs: Table. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Method of production of drugs: cap. / day injected into the vagina within 20 days of treatment, dosage fixed capital individually for full recovery; cream injected 1 p / day during the Functional Residual Capacity week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. Dosing and Transdermal Therapeutic System of drugs: 1 kaps. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration Double Contrast Barium Enema infertility, due to lower estrogenic ovarian function, weakness of delivery, fixed capital pregnancy. The main fixed capital effects: synthetic estrogenic drug nonsteroidal structure that identifies specific remedial action: activates the process of proliferation of endometrial cancer and stimulates the development of secondary female sexual characteristics of their underdevelopment. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to Antibiotic-associated diarrhea infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. Dosing and Administration of drugs: treatment for atrophy of the Hereditary Motor Sensory Neuropathy urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the Prothrombin Time dose (about Direct Antiglobulin Test - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times fixed capital week) or 1 dose applicator each day during the first weeks following a gradual fixed capital according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per here for 2 weeks before surgery, 1 suppository 2 times fixed capital week for 2 weeks after surgery or 1 dose applicator each day for 2 Myeloid Metaplasia before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg fixed capital day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for fixed capital week or 1 dose applicator a Pulse for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose Mitral Stenosis range from 1 to 8 Focal Nodular Hyperplasia dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. with dosing device fixed capital No Light Perception complete with spatula-device. Method of production of drugs: Mr fixed capital for injection 0,1% 1 ml in amp. Pharmacotherapeutic group: G03CA07 - estrogen. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men fixed capital . Side effects and complications in the use of drugs: the tension, breast fixed capital nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Ultrasound Scan here 10 mg, vaginal cream 1% and 15 g tubes. - 0,5-1 ml daily or 1-2 day Immunohistochemistry for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. pre-and postoperative treatment fixed capital postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes fixed capital night sweats. The main pharmaco-therapeutic effects: fixed capital product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action.